D
The startup operates a data-driven platform that utilizes synthetic lethality to identify novel therapeutic targets for anticancer drug development. By leveraging extensive data analysis, it enables researchers to create effective treatments for cancer, addressing the urgent need for new medicines in oncology.
성남시, 대한민국
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup operates a data-driven platform that utilizes synthetic lethality to identify novel therapeutic targets for anticancer drug development. By leveraging extensive data analysis, it enables researchers to create effective treatments for cancer, addressing the urgent need for new medicines in oncology.